Healthcare
Gedeon Richter PLC(RGEDF)
Live Price
Offline$38.33
-2.55% today
1Y Change
+40.60%
Window
Jun 23, 2025 โ Jun 9, 2026
- Market Cap
- $2.39T
- Revenue Growth
- +8.3%
- EPS Growth
- -2.8%
- Dividend Yield
- 3.9%
Coverage: 248 bars ยท Jun 23, 2025 โ Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Gedeon Richter PLC (RGEDF) is a Healthcare stock with a market cap of $2.39T and listed on OTC. The stock last traded around $38.33 and up 40.6% across the available one-year price window (Jun 23, 2025 โ Jun 9, 2026). Baseline metrics include revenue growth of +8.3%, EPS growth of -2.8%, a dividend yield of 3.9%. What stands out right now is revenue +8.3%, EPS -2.8%, free cash flow +2.3% with operating margin 33.2% and ROIC 16.6%. The dividend matters to the case here, with a current yield around 3.9%. Valuation is more restrained than many high-expectation growth names at P/E 10.3 and price/sales 2.6. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines RGEDF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+8.3% vs +7.6% peer median
Operating Margin
Above sector median
+33.2% vs +19.4% peer median
P/E
Below sector median
10.3 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 12, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +8.3% and EPS is at -2.8%, with operating margin around 33.2%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 3.9%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.1% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 12, 2026 | โ | -0.6% | +0.2% | โ |
2026 Feb 27, 2026 | โ | +0.0% | +0.0% | +0.0% |
2025 Nov 6, 2025 | โ | +0.0% | +0.0% | -5.5% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RGEDF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
RGEDF Max Drawdown
-15.63%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RGEDF and SPY.
Company Overview
Gedeon Richter PLC
Other OTC
Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. It operates through the following segments: Pharmaceuticals, Wholesale & Retail, and Others. The Pharmaceutical segment engages in research and development, manufacturing, sales and marketing of pharmaceutical products. The Wholesale & Retail segment represents the distribution of companies and pharmacies that are part of the sales network in various regional markets and, as such, convey its products to consumers. The Other segment relates to the business of the members of the group that provide marketing and sales support services. The company was founded by Gedeon Richter in 1901 and is headquartered in Budapest, Hungary.
- Leadership
- Gabor Orban
- IPO Date
- Oct 17, 2013
- Employees
- 10.9k
- Street Address
- GyOemroi Ut 19-21.
- Mailing
- Budapest, 1103
- Region
- Budapest, HU
- Reporting Currency
- USD
- Investor Line
- 36 1 431 4000
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 10.3
- EV/EBITDA
- 6.4
- Price/Sales
- 2.6
- Price/Book
- 1.7
Growth
- Revenue
- +8.3%
- EPS
- -2.8%
- Free Cash Flow
- +2.3%
Profitability
- Gross Margin
- 68.1%
- Operating Margin
- 33.2%
- Net Margin
- 25.0%
- ROE
- 17.3%
- ROIC
- 16.6%
Balance Sheet
- Debt/Equity
- 0.03
- Current Ratio
- 4.51
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.